Evidence map›Paper›PMID 39360413›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2024

CXCR3-CXCL11 Signaling Restricts Angiogenesis and Promotes Pericyte Recruitment.

Jihui Lee, Megan E Goeckel, Allison Levitas, Sarah Colijn, Jimann Shin, Anna Hindes, Geonyoung Mun, Zarek Burton, Bharadwaj Chintalapati, Ying Yin and 3 more

Abstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Jihui Lee *Department of Cell Biology and Physiology (J.L., M.E.G., A.L., S.C., G.M., Z.B., B.C., Y.Y., J.A., A.N.S.), Washington University School of Medicine, St. Louis, MO.ORCID 0009-0000-3106-8858
Megan E Goeckel *Department of Cell Biology and Physiology (J.L., M.E.G., A.L., S.C., G.M., Z.B., B.C., Y.Y., J.A., A.N.S.), Washington University School of Medicine, St. Louis, MO.ORCID 0009-0005-9267-740X
Allison LevitasDepartment of Cell Biology and Physiology (J.L., M.E.G., A.L., S.C., G.M., Z.B., B.C., Y.Y., J.A., A.N.S.), Washington University School of Medicine, St. Louis, MO.
Sarah ColijnDepartment of Cell Biology and Physiology (J.L., M.E.G., A.L., S.C., G.M., Z.B., B.C., Y.Y., J.A., A.N.S.), Washington University School of Medicine, St. Louis, MO.ORCID 0000-0003-3419-9970
Jimann ShinDepartment of Developmental Biology (J.S., A.H., L.S.-K.), Washington University School of Medicine, St. Louis, MO.ORCID 0000-0003-1027-0517
Anna HindesDepartment of Developmental Biology (J.S., A.H., L.S.-K.), Washington University School of Medicine, St. Louis, MO.
Geonyoung MunDepartment of Cell Biology and Physiology (J.L., M.E.G., A.L., S.C., G.M., Z.B., B.C., Y.Y., J.A., A.N.S.), Washington University School of Medicine, St. Louis, MO.
Zarek BurtonDepartment of Cell Biology and Physiology (J.L., M.E.G., A.L., S.C., G.M., Z.B., B.C., Y.Y., J.A., A.N.S.), Washington University School of Medicine, St. Louis, MO.
Bharadwaj ChintalapatiDepartment of Cell Biology and Physiology (J.L., M.E.G., A.L., S.C., G.M., Z.B., B.C., Y.Y., J.A., A.N.S.), Washington University School of Medicine, St. Louis, MO.
Ying YinDepartment of Cell Biology and Physiology (J.L., M.E.G., A.L., S.C., G.M., Z.B., B.C., Y.Y., J.A., A.N.S.), Washington University School of Medicine, St. Louis, MO.
Javier AbelloDepartment of Cell Biology and Physiology (J.L., M.E.G., A.L., S.C., G.M., Z.B., B.C., Y.Y., J.A., A.N.S.), Washington University School of Medicine, St. Louis, MO.ORCID 0009-0009-1134-8241
Lilianna Solnica-KrezelDepartment of Developmental Biology (J.S., A.H., L.S.-K.), Washington University School of Medicine, St. Louis, MO.ORCID 0000-0003-0983-221X
Amber N StratmanDepartment of Cell Biology and Physiology (J.L., M.E.G., A.L., S.C., G.M., Z.B., B.C., Y.Y., J.A., A.N.S.), Washington University School of Medicine, St. Louis, MO.ORCID 0000-0002-8111-4186

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Inductive and morphogenetic processes shaping the zebrafish embryonic axesR35GM118179 · NIGMS · WASHINGTON UNIVERSITY · PI LILIANNA SOLNICAKREZEL · 2016 to 2026
$7.4M
Mechanosensitive mechanisms regulating cellular coordination during tissue morphogenesis and patterningR35GM137976 · NIGMS · WASHINGTON UNIVERSITY · PI STRATMAN, AMBER NICOLE · 2020 to 2024
$2.4M
Primary cilia as regulators of vascular stability during embryonic developmentK99HL171944 · NHLBI · WASHINGTON UNIVERSITY · PI WILSON-COLIJN, SARAH ANN · 2024 to 2025
$217k
NCATS NIH HHS UL1 TR002345NHLBI NIH HHS K99 HL171944NIGMS NIH HHS R35 GM118179NIGMS NIH HHS R35 GM137976
6 · The paper itself

Abstract

backgroundEndothelial cell (EC)-pericyte interactions are known to remodel in response to hemodynamic forces; yet there is a lack of mechanistic understanding of the signaling pathways that underlie these events. Here, we have identified a novel signaling network regulated by blood flow in ECs-the chemokine receptor CXCR3 (CXC motif chemokine receptor 3) and one of its ligands, CXCL11 (CXC motif chemokine ligand 11)-that delimits EC angiogenic potential and promotes pericyte recruitment to ECs during development.

methodsWe investigated the role of CXCR3 on vascular development using both 2- and 3-dimensional in vitro assays, to study EC-pericyte interactions and EC behavioral responses to blood flow. Additionally, genetic mutants and pharmacological modulators were used in zebrafish in vivo to study the impacts of CXCR3 loss and gain of function on vascular development.

resultsIn vitro modeling of EC-pericyte interactions demonstrates that suppression of EC-specific CXCR3 signaling leads to loss of pericyte association with EC tubes. In vivo, phenotypic defects are particularly noted in the cranial vasculature, where we see a loss of pericyte association with ECs and expansion of the vasculature in zebrafish treated with the Cxcr3 inhibitor AMG487 or in homozygous

conclusionsOur results suggest that CXCR3 signaling in ECs helps promote vascular stabilization events during development by preventing EC overgrowth and promoting pericyte recruitment.

Indexed as

Chemokine CXCL11Neovascularization, PhysiologicPericytesReceptors, CXCR3Signal TransductionZebrafishZebrafish ProteinsAngiogenesisAnimalsAnimals, Genetically ModifiedCell CommunicationCell MovementCells, CulturedCoculture TechniquesEndothelial CellsHumansChemokine CXCL11CXCL11 protein, humanCXCR3 protein, humanReceptors, CXCR3Zebrafish Proteinsendothelial cellshemodynamicspericytesvascular developmentzebrafish

Identifiers

PMID39360413
PMCPMC11594002

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.